+

WO2003048187A3 - Peptides and use thereof in therapeutic agents against hiv infection - Google Patents

Peptides and use thereof in therapeutic agents against hiv infection Download PDF

Info

Publication number
WO2003048187A3
WO2003048187A3 PCT/US2002/038152 US0238152W WO03048187A3 WO 2003048187 A3 WO2003048187 A3 WO 2003048187A3 US 0238152 W US0238152 W US 0238152W WO 03048187 A3 WO03048187 A3 WO 03048187A3
Authority
WO
WIPO (PCT)
Prior art keywords
amino acids
group
acid selected
peptides
amino acid
Prior art date
Application number
PCT/US2002/038152
Other languages
French (fr)
Other versions
WO2003048187A2 (en
Inventor
Pierre-Francois Serre
Original Assignee
Mymetics Corp
Pierre-Francois Serre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0115423A external-priority patent/FR2832715A1/en
Application filed by Mymetics Corp, Pierre-Francois Serre filed Critical Mymetics Corp
Priority to AU2002351176A priority Critical patent/AU2002351176A1/en
Publication of WO2003048187A2 publication Critical patent/WO2003048187A2/en
Publication of WO2003048187A3 publication Critical patent/WO2003048187A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention provides novel peptides A peptide containing from 25 to 40 amino acids and comprising a sequence π corresponding to formula (I) WX1X2WX3X4EX5X6NYT, wherein X1 represents an amino acid selected from the group consisting of amino acids M, I, L and Q; X2 represents an amino acid selected from the group consisting of amino acids E, K, R, and Q; X3 represents an amino acid selected from the group consisting of amino acids D and E; X4 represents an amino acid selected from the group consisting of amino acids K, R, and Q; X5 represents an amino acid selected from the group consisting of amino acids V, I, and L; and X6 represents an amino acid selected from the group consisting of amino acids D, S, N, and E; and wherein letters in formula (I) other than X represent amino acids according to conventional nomenclature.
PCT/US2002/038152 2001-11-29 2002-11-27 Peptides and use thereof in therapeutic agents against hiv infection WO2003048187A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002351176A AU2002351176A1 (en) 2001-11-29 2002-11-27 Peptides and use thereof in therapeutic agents against hiv infection

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0115423 2001-11-29
FR0115423A FR2832715A1 (en) 2001-11-29 2001-11-29 New peptide containing 25 - 40 amino acids and a sequence useful as therapeutic agents in the treatment of HIV virus infections
US34049201P 2001-12-18 2001-12-18
US60/340,492 2001-12-18

Publications (2)

Publication Number Publication Date
WO2003048187A2 WO2003048187A2 (en) 2003-06-12
WO2003048187A3 true WO2003048187A3 (en) 2004-04-29

Family

ID=26213281

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/038152 WO2003048187A2 (en) 2001-11-29 2002-11-27 Peptides and use thereof in therapeutic agents against hiv infection

Country Status (2)

Country Link
AU (1) AU2002351176A1 (en)
WO (1) WO2003048187A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140335119A1 (en) * 2004-02-06 2014-11-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) POLYPEPTIDE DERIVED FROM gp41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUAL
CN104427991A (en) * 2012-06-27 2015-03-18 耶达研究与发展有限公司 Peptides derived from HIVGP41 for treating T-cell mediated pathologies

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US5656480A (en) * 1992-07-20 1997-08-12 Duke University Compounds which inhibit HIV replication
US5840843A (en) * 1992-03-26 1998-11-24 The New York Blood Center Synthetic polypeptides as inhibitors of HIV-1

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840843A (en) * 1992-03-26 1998-11-24 The New York Blood Center Synthetic polypeptides as inhibitors of HIV-1
US5656480A (en) * 1992-07-20 1997-08-12 Duke University Compounds which inhibit HIV replication
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission

Also Published As

Publication number Publication date
WO2003048187A2 (en) 2003-06-12
AU2002351176A8 (en) 2003-06-17
AU2002351176A1 (en) 2003-06-17

Similar Documents

Publication Publication Date Title
EP0528312A3 (en) Cyclic peptides and use thereof
IL213319A (en) Polylysine peptides for use in the treatment of bacterial infections
WO2002031109A3 (en) Intracellular delivery of biological effectors by novel transporter peptide sequences
WO2004108938A3 (en) Peptide ligands of dendritic cells for nucleic acid vector targeting
WO2003037932A3 (en) Human coagulation factor vii polypeptides
WO1999006440A8 (en) Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
WO2002072616A3 (en) Transfection complexes
AU2003286404A1 (en) Peptide nanostructures, methods for their preparation and use
WO2003048205A3 (en) Novel proteins with il-6 inhibiting activity
BR0312889A (en) Pegged t20 polypeptide
AU3258197A (en) Peptides
ATE474589T1 (en) ANGIOGENIC PEPTIDES AND THEIR USES
EP0816504A3 (en) Platelet activating factor acetylhdrolase, and gene thereof
WO2003048187A3 (en) Peptides and use thereof in therapeutic agents against hiv infection
ATE296314T1 (en) PEPTIDES OF THE ENV GENE FROM THE CAT IMMUNE DEFICIENCY VIRUS AND THEIR USE
ATE245168T1 (en) PEPTIDES THAT EXHIBIT ANTI-CELL ADHESION ACTIVITY
CA2406884A1 (en) Novel collectins
EP1790655A3 (en) Biologically active peptides
WO2002085934A3 (en) Antibacterial peptides, compositions containing same and uses thereof
AU2003264535A1 (en) Tumor antigen protein and utilization thereof
WO2004052916A3 (en) Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids
AU773969C (en) Novel tachykinin peptides, precursor peptides thereof and genes encoding the same
WO2003018806A1 (en) Novel human bmcc1 gene
CA2367003A1 (en) Peptides useful in treating multiple sclerosis and a pharmaceutical composition comprising the same
WO1998055506A3 (en) Thrombin-inhibiting peptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载